Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 26.75 is 223% above its 3-year average of 8.27, near the high end of its 3-year range (0.00–26.75).
As of the fiscal period ended Tuesday, June 30, 2026. 82.24% above its 12-month average of 14.68.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 26.75.
QUICK RATIO (ACID-TEST)
26.75
QUICK RATIO (ACID-TEST) AVG TTM
14.68
QUICK RATIO (ACID-TEST) AVG 3Y
11.09
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+82.24%
CURRENT VS 3Y AVG
+141.26%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+698.40%
vs the sector median at left
OnKure Therapeutics, Inc.
Market Cap
$97.60M
Quick Ratio (Acid-Test)
26.75
TTM Avg
14.68
3Y Avg
11.09
5Y Avg
N/A
Market Cap
$97.64M
Quick Ratio (Acid-Test)
9.55
TTM Avg
7.84
3Y Avg
7.78
5Y Avg
8.56
Market Cap
$96.58M
Quick Ratio (Acid-Test)
1.12
TTM Avg
0.72
3Y Avg
0.57
5Y Avg
0.57
Market Cap
$96.06M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$94.94M
Quick Ratio (Acid-Test)
7.92
TTM Avg
8.53
3Y Avg
9.72
5Y Avg
13.43
Market Cap
$101.36M
Quick Ratio (Acid-Test)
1.83
TTM Avg
1.56
3Y Avg
1.30
5Y Avg
1.30
Market Cap
$103.09M
Quick Ratio (Acid-Test)
8.54
TTM Avg
8.31
3Y Avg
10.99
5Y Avg
13.37
Market Cap
$104.00M
Quick Ratio (Acid-Test)
7.28
TTM Avg
6.67
3Y Avg
7.13
5Y Avg
10.02
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | $97.60M | 26.75 | 14.68 | 11.09 | N/A |
| PolyPid Ltd. (PYPD)vs › | $96.75M | 1.14 | 1.56 | 1.41 | 4.39 |
| Korro Bio, Inc. (KRRO)vs › | $97.64M | 9.55 | 7.84 | 7.78 | 8.56 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | 1.12 | 0.72 | 0.57 | 0.57 |
| Conexeu Sciences Inc. (CNXU)vs › | $96.06M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $94.94M | 7.92 | 8.53 | 9.72 | 13.43 |
| The Joint Corp. (JYNT)vs › | $101.36M | 1.83 | 1.56 | 1.30 | 1.30 |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.09M | 8.54 | 8.31 | 10.99 | 13.37 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.00M | 7.28 | 6.67 | 7.13 | 10.02 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.18M | 13.53 | 12.93 | 9.36 | 9.36 |
Quick Ratio
26.75
Excludes inventory
Current Ratio
26.75
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 26.75 |
| 2026-03-31 | 13.78 |
| 2025-12-31 | 10.28 |
| 2025-09-30 | 11.45 |
| 2025-06-30 | 11.13 |
| 2025-03-31 | 11.17 |
| 2024-12-31 | 10.73 |
| 2024-09-30 | 23.71 |
| 2024-06-30 | 1.83 |
| 2024-03-31 | 4.09 |
| 2023-12-31 | 4.64 |
| 2023-09-30 | 9.49 |
| 2023-06-30 | 10.65 |
| 2023-03-31 | 0.00 |
